Madrigal Pharmaceuticals, Inc.
MDGL· Nasdaq
Released May 8, 2019, before the open
10-Q filed May 8, 2019, 38 days after period end · 0001104659-19-027633
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$15.08M | -$6.36M | -$6.00M | — |
| EPS Diluted |
Madrigal Pharmaceuticals, Inc. · CIK 1157601 · Engraved from SEC EDGAR
| -$0.98 |
| -$0.45 |
| -$0.50 |
| -$9.72 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.